Literature DB >> 10192800

Plasma membrane disruption underlies injury of the corneal endothelium by ultrasound.

K Saito1, K Miyake, P L McNeil, K Kato, K Yago, N Sugai.   

Abstract

The nature and the extent of acute injury to corneal endothelial cells caused by exposure to ultrasound radiation were characterized, as well as the long-term reaction of these cells to this form of injury. It was found that the degree of lethal cell injury induced by ultrasound scaled with exposure intensity and duration. Immediate changes in plasma membrane permeability were induced by ultrasound exposure. This ultrasound-induced permeability change was, however, transient in many cells, allowing them to trap and retain a normally impermeant tracer, fluorescein dextran, in cytosol. Microvilli were present on ultrasound treated cells in far greater density than on control cells, characteristic of exocytosis-based resealing. Cultures containing a majority of transiently permeabilized endothelial cells were morphologically indistinguishable from untreated control cultures, and the fluorescein dextran-labeled cells in these populations locomoted and divided normally. We conclude that cell death due to ultrasound exposure can occur rapidly via a necrotic mechanism that can be attributed to mechanically induced damage to the plasma membrane. However, not all cells injured become necrotic: some survive and appear to behave normally after exposure. Conditions that favor plasma membrane disruption resealing, e.g. that result in sub-lethal rather than lethal cell injury, may mitigate the reduction in corneal endothelial cell density consequent on phacoemulsification and aspiration surgery. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10192800     DOI: 10.1006/exer.1998.0626

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  15 in total

Review 1.  Ultrasonic drug delivery--a general review.

Authors:  William G Pitt; Ghaleb A Husseini; Bryant J Staples
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

2.  The comet assay to determine the mode of cell death for the ultrasonic delivery of doxorubicin to human leukemia (HL-60 Cells) from Pluronic P105 micelles.

Authors:  Ghaleb A Husseini; Kim L O'Neill; William G Pitt
Journal:  Technol Cancer Res Treat       Date:  2005-12

3.  Modeling and sensitivity analysis of acoustic release of Doxorubicin from unstabilized pluronic P105 using an artificial neural network model.

Authors:  Ghaleb A Husseini; Nabil M Abdel-Jabbar; Farouq S Mjalli; William G Pitt
Journal:  Technol Cancer Res Treat       Date:  2007-02

Review 4.  State-of-the-art materials for ultrasound-triggered drug delivery.

Authors:  Shashank R Sirsi; Mark A Borden
Journal:  Adv Drug Deliv Rev       Date:  2013-12-31       Impact factor: 15.470

5.  Ultrasound activates the TM ELAM-1/IL-1/NF-kappaB response: a potential mechanism for intraocular pressure reduction after phacoemulsification.

Authors:  Nan Wang; Shravan K Chintala; M Elizabeth Fini; Joel S Schuman
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

6.  Extensive mononuclear infiltration and myogenesis characterize recovery of dysferlin-null skeletal muscle from contraction-induced injuries.

Authors:  Joseph A Roche; Richard M Lovering; Renuka Roche; Lisa W Ru; Patrick W Reed; Robert J Bloch
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-18       Impact factor: 4.249

Review 7.  Micelles and nanoparticles for ultrasonic drug and gene delivery.

Authors:  Ghaleb A Husseini; William G Pitt
Journal:  Adv Drug Deliv Rev       Date:  2008-04-04       Impact factor: 15.470

Review 8.  Ultrasonic-activated micellar drug delivery for cancer treatment.

Authors:  Ghaleb A Husseini; William G Pitt
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

Review 9.  Plasma membrane disruption (PMD) formation and repair in mechanosensitive tissues.

Authors:  Mackenzie L Hagan; Vanshika Balayan; Meghan E McGee-Lawrence
Journal:  Bone       Date:  2021-04-21       Impact factor: 4.626

10.  Ultrasonically enhanced rifampin activity against internalized Staphylococcus aureus.

Authors:  Si-Feng Shi; Xian-Long Zhang; Chen Zhu; DE-Sheng Chen; Yong-Yuan Guo
Journal:  Exp Ther Med       Date:  2012-10-22       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.